Aiocd Pharma Profile
Key Indicators
- Authorised Capital ₹ 76.00 Cr
as on 24-07-2024
- Paid Up Capital ₹ 27.47 Cr
as on 24-07-2024
- Company Age 18 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 11.03%
(FY 2023)
- Profit -9.74%
(FY 2023)
- Ebitda -85.96%
(FY 2023)
- Net Worth 1.38%
(FY 2023)
- Total Assets 0.93%
(FY 2023)
About Aiocd Pharma
The Corporate was formerly known as Maharashtra Safe Chemists And Distributors Alliance Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 76.00 Cr and a paid-up capital of Rs 27.47 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Aiocd Pharma Limited India are Ravindra Patil as CFO and Rinku Gadani as Company Secretary. Devesh Pathak, Vaijanath Jagushte, Jagannath Shinde, and Seven other members serve as directors at the Company.
- CIN/LLPIN
U24239MH2006PLC165149
- Company No.
165149
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
16 Oct 2006
- Date of AGM
22 Dec 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Aiocd Pharma?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ravindra Patil | CFO | 11-Feb-2022 | Current |
Rinku Gadani  | Company Secretary | 01-Dec-2022 | Current |
Board Members(10)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Devesh Pathak | Director | 28-Aug-2019 | Current |
| Vaijanath Jagushte | Director | Current | |
| Jagannath Shinde | Director | 16-Oct-2006 | Current |
| Jashvant Prahladbhai | Director | Current | |
| Vijay Patil | Director | 15-Feb-2019 | Current |
| Raveendran Balkrishnan | Director | Current |
Financial Performance and Corporate Structure Insights of Aiocd Pharma.
Aiocd Pharma Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 11.03% increase. The company also saw a slight decrease in profitability, with a 9.74% decrease in profit. The company's net worth moved up by a moderate rise of 1.38%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aiocd Pharma?
In 2023, Aiocd Pharma had a promoter holding of 1.32% and a public holding of 98.68%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
R+B Filter Manufacturing Enterprises Private LimitedActive 19 years 1 dayDevesh Pathak is a mutual person
- Devesh Pathak Professional Solutions Private LimitedActive 33 years 6 months
Devesh Pathak is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Aiocd Pharma?
Aiocd Pharma has a workforce of 42 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aiocd Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aiocd Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
